Author: | Rusch, V. W. |
Article Title: | Clinical features and current treatment of diffuse malignant pleural mesothelioma |
Abstract: | Malignant pleural mesothelioma is an uncommon cancer for which the major risk factor is prior asbestos exposure. During the past decade, there has been progress in the diagnosis, staging and biology of mesothelioma. Treatment remains controversial and ranges from supportive care alone to aggressive multimodality therapy. Prospective clinical trials in carefully staged patients are needed to determine what approaches to treatment may confer a survival benefit. © 1995, All rights reserved. |
Keywords: | cancer chemotherapy; cancer surgery; clinical trial; histopathology; cisplatin; doxorubicin; cancer risk; multimodality cancer therapy; antineoplastic agents; conference paper; cancer radiotherapy; combined modality therapy; treatment; cancer staging; staging; antineoplastic agent; lymphatic metastasis; neoplasm staging; carboplatin; cancer immunotherapy; radiotherapy; risk factors; tomography, x-ray computed; cyclophosphamide; vinblastine; immunotherapy; diagnosis; pleura mesothelioma; mesothelioma; vindesine; mitomycin; pleural neoplasms; clinical trials; azacitidine; clinical examination; asbestos; asbestosis; pleural mesothelioma; human; priority journal |
Journal Title: | Lung Cancer |
Volume: | 12 |
Issue: | Suppl. 2 |
ISSN: | 0169-5002 |
Publisher: | Elsevier Ireland Ltd. |
Date Published: | 1995-06-01 |
Start Page: | S127 |
End Page: | S146 |
Language: | English |
DOI: | 10.1016/s0169-5002(10)80011-x |
PUBMED: | 7551944 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Article -- Export Date: 28 August 2018 -- Source: Scopus |